Nukkleus (NUKKW) Competitors $0.25 -0.09 (-26.49%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NUKKW vs. ADVWW, MMA, AUUDW, BIAFW, CFFEW, GSMGW, DKDCW, DTSTW, ESGLW, and XELAPShould you be buying Nukkleus stock or one of its competitors? The main competitors of Nukkleus include Advantage Solutions (ADVWW), Alta Global Group (MMA), Auddia (AUUDW), bioAffinity Technologies (BIAFW), CF Acquisition Corp. VIII (CFFEW), Cheer (GSMGW), Data Knights Acquisition (DKDCW), Data Storage (DTSTW), ESGL (ESGLW), and Exela Technologies (XELAP). These companies are all part of the "business services" industry. Nukkleus vs. Advantage Solutions Alta Global Group Auddia bioAffinity Technologies CF Acquisition Corp. VIII Cheer Data Knights Acquisition Data Storage ESGL Exela Technologies Nukkleus (NASDAQ:NUKKW) and Advantage Solutions (NASDAQ:ADVWW) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, community ranking, institutional ownership, profitability and media sentiment. Does the media refer more to NUKKW or ADVWW? In the previous week, Advantage Solutions had 2 more articles in the media than Nukkleus. MarketBeat recorded 2 mentions for Advantage Solutions and 0 mentions for Nukkleus. Advantage Solutions' average media sentiment score of 1.20 beat Nukkleus' score of 0.00 indicating that Advantage Solutions is being referred to more favorably in the news media. Company Overall Sentiment Nukkleus Neutral Advantage Solutions Positive Which has better valuation & earnings, NUKKW or ADVWW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNukkleus$10.75MN/AN/AN/AN/AAdvantage Solutions$3.99BN/AN/AN/AN/A Does the MarketBeat Community prefer NUKKW or ADVWW? Nukkleus and Advantage Solutions both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNukkleusN/AN/AAdvantage SolutionsN/AN/A Is NUKKW or ADVWW more profitable? Company Net Margins Return on Equity Return on Assets NukkleusN/A N/A N/A Advantage Solutions N/A N/A N/A SummaryAdvantage Solutions beats Nukkleus on 3 of the 3 factors compared between the two stocks. Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Get Nukkleus News Delivered to You Automatically Sign up to receive the latest news and ratings for NUKKW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUKKW vs. The Competition Export to ExcelMetricNukkleusSoftware IndustryComputer SectorNASDAQ ExchangeMarket CapN/A$5.82B$26.13B$9.08BDividend YieldN/A3.22%2.79%4.23%P/E RatioN/A749.39237.6617.18Price / SalesN/A5,510.953,364.36117.05Price / CashN/A16.5535.9037.85Price / BookN/A15.778.164.78Net IncomeN/A$61.87M$685.86M$225.60M7 Day PerformanceN/A-0.57%0.42%-1.23%1 Month PerformanceN/A5.86%5.21%0.46%1 Year PerformanceN/A44.85%22.44%15.24% Nukkleus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUKKWNukkleusN/A$0.25-26.5%N/AN/A$0.00$10.75M0.0010Gap DownHigh Trading VolumeADVWWAdvantage SolutionsN/A$0.02flatN/A-85.1%$0.00$3.99B0.0075,000News CoveragePositive NewsGap DownMMAAlta Global GroupN/A$1.43-4.0%N/AN/A$0.00$562,312.000.00N/ANews CoverageGap DownAUUDWAuddiaN/A$0.02flatN/AN/A$0.00N/A0.0020Positive NewsGap UpBIAFWbioAffinity TechnologiesN/A$0.52flatN/A+487.1%$0.00$9.37M0.0010News CoverageCFFEWCF Acquisition Corp. VIIIN/A$0.05flatN/AN/A$0.00N/A0.003GSMGWCheerN/A$0.00flatN/A-72.7%$0.00$155.95M0.00160Positive NewsGap DownDKDCWData Knights AcquisitionN/A$0.02-38.5%N/A+309.2%$0.00N/A0.002Gap DownHigh Trading VolumeDTSTWData StorageN/A$0.68+1.5%N/A+264.9%$0.00$25.14M0.0060Positive NewsESGLWESGLN/A$0.02flatN/A+515.4%$0.00$6.26M0.00N/APositive NewsXELAPExela TechnologiesN/A$0.23-34.8%N/A-86.2%$0.00$1.02B0.0017,000News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Advantage Solutions Competitors Alta Global Group Competitors Auddia Competitors bioAffinity Technologies Competitors CF Acquisition Corp. VIII Competitors Cheer Competitors Data Knights Acquisition Competitors Data Storage Competitors ESGL Competitors Exela Technologies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NUKKW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.